MIM
ZYME icon

Monashee Investment Management’s Zymeworks ZYME Stock Holding History

Monashee Investment Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-80,000
Closed -$1.76M – 181
2019
Q2 		$1.76M Buy
+80,000
New +$1.47M 0.46% 63
2018
Q2 		– Hold
0
– – – 54

Other funds holding ZYME

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Monashee Investment Management's ZYME Position: Q3 2019 in Review

Monashee Investment Management sold out of Zymeworks (ZYME) in Q3 2019, closing a stake of 80,000 shares — an estimated $1.76M sold.

Monashee Investment Management first reported a position in ZYME in Q2 2019 and held it in 1 quarter. The position peaked at $1.76M in Q2 2019. 74 funds tracked by Wall St. Rank hold ZYME as of Q3 2019.

  • Monashee Investment Management reported no remaining Zymeworks position as of Q3 2019 after selling out during the quarter.
  • Monashee Investment Management sold 80,000 Zymeworks shares in Q3 2019, an estimated $1.76M.
  • Monashee Investment Management first reported a position in Zymeworks in Q2 2019 and held it in 1 quarter.
  • Monashee Investment Management's Zymeworks position peaked at $1.76M in Q2 2019.
  • 74 funds tracked by Wall St. Rank held Zymeworks as of Q3 2019.

Based on Monashee Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.